Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines
Recruiting · NCT06904287 · Interventional (participants receive a specific treatment) · Lead sponsor: Wake Forest University Health Sciences
View the official record on ClinicalTrials.gov →Interventions studied
MagnesiumPlacebo
What this trial is about
The purpose of this research study is to find out if using magnesium in addition to prochlorperazine will help reduce your migraine pain.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age ≥ 18 years or older
- Able to provide informed consent
- English speaking
- Primary diagnosis of migraine. Patient with a previous diagnosis of migraine, who experience headaches with typical migraine features (e.g at least 2-3 of the following: recurrent, unilateral, pounding or throbbing in nature, associated with nausea), AND with a clinical exclusion of migraine mimics
Exclusion criteria
- Pregnancy defined as a positive urine HCG
- Allergy or sensitivity to study drug
- Stated history of renal insufficiency
- Documented history of myasthenia gravis
- Consumption of study drug within 48 hours prior to enrollment
- Previously enrolled in this trial during a different patient encounter
Where it is running
1 location listed across 1 US state.
- Advocate Christ Medical Center Emergency Department - Oak Lawn, Illinois, United States